parkinsons disease - search results

Dr Nauf AlBendar, Doctor of Clinical Medicine & Founder of The Womb Effect, introduces spina bifida, the primary cause of foetal loss and substantial disabilities in newborns.

One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).

Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.

Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.

George Ordiway, a PhD student in the laboratory of Dr. Jason Tait Sanchez at Northwestern University, discusses how patterned activity in the nervous system permits a wide range of biologically relevant functions, including auditory development.

Alex Schiphorst, Science Communication and Policy Officer discusses the vital role of chemistry when it comes to the future of Europe.

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention

Industrial strategy boost will help speed up the development of new medical treatments with £70 million funding The £70 million of funding will be used to create new manufacturing centres to help speed up the development of new medical treatments according to new Science Minister, Sam Gyiamah. The money forms part...

Dr. Arun Srivastava, George H. Kitzman Professor of Genetics, from the University of Florida describes the rationale and strategies for the development of next generation (NextGen), generation X (GenX) and optimised (Opt) recombinant AAV vectors for human gene therapy Recombinant AAV vectors have been, or are currently being, used in...

Table Tennis Scotland awarded £45,000 to become dementia friendly Table Tennis Scotland is receiving £35,000 from the Life Changes Trust and £10,000 from Sportscotland to become dementia friendly. Table Tennis Scotland successfully ran two pilot projects in Dundee and Haddington for over 50's with dementia and Parkinson's disease. As a result, they are now...

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Executive Director of the European College of Neuropsychopharmacology (ECNP), Alexander Schubert looks at how science is unravelling the complexity of the human brain

Pamela Lein, University of California, looks at whether environmental chemicals influence individual risk for the diagnosis of neurodevelopmental disorders

Parkinson’s rating scales are a vital assessment tool, but have their limitations. Jennifer Stratten explains how and why the EPDA developed a new one

Today, stakeholders from across the globe will unite to raise awareness of Parkinson’s during a dedicated campaign

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

Professor Raffaella Rumiati shares some insights into food recognition and eating behaviours that are emerging from food neuroscience research at SISSA In recent years there has been growing interest in finding out how our brain processes food cues and directs our food choices. Food is essential because it provides the...

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will be the 200th year since James Parkinson wrote his seminal paper on ‘the Shaking Palsy’. Since that time there have been major developments in the...